Impact of COVID-19 on in-hospital cardiac arrest outcomes: An updated meta-analysis

Bielski, Karol; Makowska, Karolina; Makowski, Adam; Kopiec, Tomasz; Malecka, Mariola; Pruc, Michał; Rafique, Zubaid; Peacock, Frank; Denegri, Andrea; Szarpak, Łukasz

doi:10.5603/cj.a2021.0168

Cited by 7 publications

(8 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar to our finding, in a meta-analysis by Bielski et al, subgroup analysis comparing ROSC between COVID-19 and non-COVID-19 patients found lower rate of ROSC in the COVID-19 population (33.9%) as compared to the non-COVID-19 patients (52.1%) [21]. A proportional prevalence meta-analysis including 4 studies and 943 IHCA patients with COVID-19 by Mir et al [22] reported a lower pooled prevalence of ROSC (39%) than our study (52.83%).…”

Section: Discussionsupporting

confidence: 92%

Outcome of In-Hospital Cardiac Arrest among Patients with COVID-19: A Systematic Review and Meta-Analysis

Shrestha

Sedhai

Dawadi

et al. 2023

JCM

View full text Add to dashboard Cite

Background: Outcomes following in-hospital cardiac arrest (IHCA) in patients with COVID-19 have been reported by several small single-institutional studies; however, there are no large studies contrasting COVID-19 IHCA with non-COVID-19 IHCA. The objective of this study was to compare the outcomes following IHCA between COVID-19 and non-COVID-19 patients. Methods: We searched databases using predefined search terms and appropriate Boolean operators. All the relevant articles published till August 2022 were included in the analyses. The systematic review and meta-analysis were conducted as per Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. An odds ratio with a 95% confidence interval (CI) was used to measure effects. Results: Among 855 studies screened, 6 studies with 27,453 IHCA patients (63.84% male) with COVID-19 and 20,766 (59.7% male) without COVID-19 were included in the analysis. IHCA among patients with COVID-19 has lower odds of achieving return of spontaneous circulation (ROSC) (OR: 0.66, 95% CI: 0.62–0.70). Similarly, patients with COVID-19 have higher odds of 30-day mortality following IHCA (OR: 2.26, 95% CI: 2.08–2.45) and have 45% lower odds of cardiac arrest because of a shockable rhythm (OR: 0.55, 95% CI: 0.50–0.60) (9.59% vs. 16.39%). COVID-19 patients less commonly underwent targeted temperature management (TTM) or coronary angiography; however, they were more commonly intubated and on vasopressor therapy as compared to patients who did not have a COVID-19 infection. Conclusions: This meta-analysis showed that IHCA with COVID-19 has a higher mortality and lower rates of ROSC compared with non-COVID-19 IHCA. COVID-19 is an independent risk factor for poor outcomes in IHCA patients.

show abstract

Section: Discussionsupporting

confidence: 92%

Outcome of In-Hospital Cardiac Arrest among Patients with COVID-19: A Systematic Review and Meta-Analysis

Shrestha

Sedhai

Dawadi

et al. 2023

JCM

View full text Add to dashboard Cite

show abstract

“…if necessary. We performed a systematic assessment of bias in the included studies using the Cochrane criteria [ 22 ]. For this purpose, a tool for Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) [ 23 ] was used.…”

Section: Methodsmentioning

confidence: 99%

Effect of Coronary Artery Disease on COVID-19—Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis

Szarpak

Mierzejewska

Jurek

et al. 2022

Biology

Self Cite

View full text Add to dashboard Cite

Coronary artery disease (CAD) is the leading cause of death worldwide. Patients with pre-existing CAD were shown to have a more severe course of COVID-19, but this association has not been clarified. We performed a meta-analysis to determine the association between CAD and COVID-19 outcomes. We searched Scopus, Medline (PubMed), Web of Science, Embase, and Cochrane databases up to November 2nd, 2021. There were 62 studies with a total population of 49,286 patients included in the meta-analysis. CAD occurrence in survivor vs. non-survivor groups varied and amounted to 9.2% vs. 22.9%, respectively (OR = 0.33; 95%CI: 0.29 to 0.39; I2 = 70%; p < 0.001). CAD was also associated with increased severity of COVID-19 disease and was (10.8% vs. 5.6%, respectively, for severe vs. non-severe groups (OR = 2.28; 95%CI: 1.59 to 3.27; I2 = 72%; p < 0.001). The role of history of CAD in mortality and severe condition in COVID-19 presents itself as prominent—although a risk of bias in retrospective trials needs to be assessed, in case of our meta-analysis the statistically significant results when it comes to higher mortality among patients with CAD compared to non-CAD patients, a more severe condition observed in patients with CAD, and a visibly more frequent admission to intensive care unit in patients with CAD, it seems that an incidence of cardiovascular events plays a role in COVID-19 prognosis.

show abstract

“… 49 In a meta-analysis of 3 studies of in-hospital cardiac arrest, SARS-CoV 2 infection was associated with lower rates of shockable rhythm (9.6% vs. 19.8%, p< 0.001), lower rates of ROSC (33.9% vs. 52.1%, p< 0.001), and higher 30-day mortality (77.2% vs. 59.7%, p=0.003). 50 …”

Section: Introductionmentioning

confidence: 99%

Impact of COVID-19 on Nonpulmonary Critical Illness

Pirzadeh

Prescott

2023

Clinics in Chest Medicine

View full text Add to dashboard Cite

Impact of COVID-19 on in-hospital cardiac arrest outcomes: An updated meta-analysis

Cited by 7 publications

References 37 publications

Outcome of In-Hospital Cardiac Arrest among Patients with COVID-19: A Systematic Review and Meta-Analysis

Outcome of In-Hospital Cardiac Arrest among Patients with COVID-19: A Systematic Review and Meta-Analysis

Effect of Coronary Artery Disease on COVID-19—Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis

Impact of COVID-19 on Nonpulmonary Critical Illness

Contact Info

Product

Resources

About